COLLECTIONS
WORKFLOWS

Recent Finacing
Recent Raise
Exuma Biotech (formerly F1 Oncology) is a clinical-stage developer of CAR-T therapies that builds logic-gated, tumor-microenvironment-restricted and same-day point-of-care CAR-T platforms using globally integrated R&D and informatics teams.